Rejected at 12:53 a.m. Nov, 01, 2023 ] by dollajas
Author: shmuelsash
Related Note: 1509226551864
Rationale for change

Clarified cloze

Rejection reason

no source that amifostine is given to all pts who are on the drug

Text Text
Extra
To prevent possible nephrotoxicity; along with amifostine
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy



Watch Platins
Sketchy 2

Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize



Physeo
Empty field
Bootcamp
Watch associated Bootcamp video - Cellular Injury and Neoplasia: Cell Cycle Independent Drug Targets

Watch associated Bootcamp video - Principles of Oncology and Therapeutics: Cell Cycle Independent Drug Targets
OME

Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#SketchyPharm::08_Antineoplastics::02_DNA_&_Cellular_Division::02_Platins !AK_UpdateTags::Step1decks::Lolnotacop::Drugs #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::08_Principles_of_Oncology_and_Therapeutics::11_Cell_Cycle_Independent_Drug_Targets #AK_Step1_v12::#B&B::11_Hematology::04_Cancer_Drugs::05_DNA_Drugs #AK_Step1_v12::#FirstAid::05_Pharm::03_Toxicities_and_Adverse_Effects::12_Drug_reactions-multiorgan #AK_Original_Decks::Step_1::Lolnotacop::Drugs #AK_Step1_v12::#OME_banner #AK_Step2_v12::#SketchyIM::04_Nephrology_&_Urology::05_Retired_Lessons::01_AKI_SOAP_[OLD_VERSION] #AK_Step1_v12::#Bootcamp::Pathology::02_Cellular_Injury_&_Neoplasia::11_Cell_Cycle_Independent_Drug_Targets #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::14_Platinum_compounds::*Platinum_Analogs #AK_Step1_v12::#Pixorize::03_Pharmacology::12_Oncology_Pharm::12_Cisplatin/Carboplatin/Oxaliplatin